Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ter Arkh ; 61(2): 104-8, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2786260

RESUMO

Monoclonal antibodies (MCA) LT1, LT2 and LT7 were characterized. It was established that MCA LT1 and LT2 (IgG1 and IgM classes, respectively) interacted with antigen 67 kD, and MCA LT7 (IgGZa)--with antigen 40 kD. MCA LT1, LT2 and LT7 were shown to identify normal and neoplastic cells of T-lymphoid type. MCA LT1 and LT2 also reacted with B-lymphocytes of chronic lymphocytic leukemic patients. MCA LT1 and LT2 were referred to CD5 (Cluster of Differentiation) and MCA LT7--to CD7 by the molecular weight of an identified antigen and the spectrum of its expression. The importance of MCA studied in the diagnosis of subtypes of acute and chronic lymphocytic leukemia has been confirmed.


Assuntos
Anticorpos Monoclonais , Antígenos de Neoplasias/análise , Linfócitos B/imunologia , Biomarcadores Tumorais/análise , Leucemia/diagnóstico , Transtornos Linfoproliferativos/diagnóstico , Linfócitos T/imunologia , Anticorpos Monoclonais/imunologia , Antígenos de Neoplasias/imunologia , Biomarcadores Tumorais/imunologia , Humanos , Leucemia/imunologia , Contagem de Leucócitos , Transtornos Linfoproliferativos/imunologia
2.
Pediatriia ; (2): 30-4, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2726363

RESUMO

The present investigation has demonstrated that it is advisable to specify different immunologic subvarieties of acute lymphoblastic leukemia based on the detection of superficial markers of blast cells. Acute lymphoblastic leukemia subvarieties are characterized by different clinical and hematological manifestations and differ with respect to the sensitivity to cytostatic therapy. The duration of remissions and lifespans was different in children belonging to different groups.


Assuntos
Leucemia-Linfoma Linfoblástico de Células Precursoras/imunologia , Adolescente , Fatores Etários , Linfoma de Burkitt/tratamento farmacológico , Linfoma de Burkitt/imunologia , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Leucemia-Linfoma de Células T do Adulto/tratamento farmacológico , Leucemia-Linfoma de Células T do Adulto/imunologia , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras B/tratamento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras B/imunologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/classificação , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Prognóstico , Fatores Sexuais
3.
Vopr Med Khim ; 34(6): 71-6, 1988.
Artigo em Russo | MEDLINE | ID: mdl-2853490

RESUMO

Activities of the enzymes, responsible for degradation of purine nucleotides in leukocytes, were distinctly dissimilar in M1, M2, M4 and M6 variants of acute non-lymphoblastic leukosis studied in 34 patients. Differentiation of leukemic cells was shown to be due to alterations in activity of adenosine deaminase and purine nucleoside phosphorylase, which were oppositely directed as compared with those observed in lymphoblasts under conditions of acute lymphoblast leukosis. Evaluation of activities of adenosine deaminase, purine nucleoside phosphorylase and 5'-nucleotidase is of importance for characteristics of individual variants of acute non-lymphoblastic leukosis and for elucidation of the state of leukemic clone differentiation, which may affect the efficiency of the therapeutic measures used.


Assuntos
Granulócitos/metabolismo , Leucemia Mieloide Aguda/metabolismo , Nucleotídeos de Purina/metabolismo , 5'-Nucleotidase , Adenosina Desaminase/sangue , Adenosina Desaminase/metabolismo , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Granulócitos/enzimologia , Humanos , Leucemia Mieloide Aguda/sangue , Leucemia Mieloide Aguda/patologia , Pessoa de Meia-Idade , Nucleotidases/sangue , Nucleotidases/metabolismo , Nucleotídeos de Purina/sangue , Purina-Núcleosídeo Fosforilase/sangue , Purina-Núcleosídeo Fosforilase/metabolismo , Recidiva
4.
Vopr Onkol ; 34(4): 421-5, 1988.
Artigo em Russo | MEDLINE | ID: mdl-3376454

RESUMO

Natural killer (NK) activity was studied in healthy children, (16) and those with acute leukemia at different phases of the disease (63). Patients' age ranged 3-11 years. NK activity was measured by release of 51Cr from the labelled K 562 target cells. A sharp decrease in NK activity was found in the acute phase, irrespective of the morphologic pattern of acute leukemia, the degree of blastosis and therapy. 75% of patients achieving remission revealed a decreased NK activity within the first 24 months, while in 25% it was normal. At 3 years and later, the majority of responders showed normal NK activity.


Assuntos
Células Matadoras Naturais/imunologia , Leucemia/imunologia , Doença Aguda , Criança , Pré-Escolar , Testes Imunológicos de Citotoxicidade , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...